Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Pulmonary Embolism 1

Interventions

apixaban 5Dalteparin 5edoxaban 2bemiparin 2abelacimab 2Tinzaparin 2Nadroparin 2MAA868 2Heparin, Low-Molecular-Weight 2Enoxaparin 2reviparin 1isoquercitrin 1certoparin 1atezolizumab 1acarboxyprothrombin 1Warfarin 1Rivaroxaban 1Phenprocoumon 1Intermittent Pneumatic Compression Devices 1Fondaparinux 1Dabigatran 1Bevacizumab 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Venous Thrombosis × Dabigatran × Clear all
NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡